RAF MUTATION
Clinical trials for RAF MUTATION explained in plain language.
Never miss a new study
Get alerted when new RAF MUTATION trials appear
Sign up with your email to follow new studies for RAF MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough cancers: early trial tests targeted drug combo
Disease control TerminatedThis early-stage clinical trial tested a new drug called DCC-3084, both alone and combined with other cancer therapies, for people with advanced solid tumors driven by specific genetic mutations. The study aimed to find a safe dose and see if the treatment could shrink tumors in …
Matched conditions: RAF MUTATION
Phase: PHASE1 • Sponsor: Deciphera Pharmaceuticals, LLC • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Targeted drug trial for Tough-to-Treat cancers halted
Disease control TerminatedThis study tested an experimental drug called DAY101 (tovorafenib) in people aged 12 and older with advanced solid tumors that had stopped responding to other treatments. The goal was to see if the drug could shrink or control tumors that have specific genetic changes. The trial …
Matched conditions: RAF MUTATION
Phase: PHASE2 • Sponsor: Day One Biopharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC